How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection-Reference-Cited by-同舟云学术

How to adapt an intestinal microbiota transplantation programme to reduce the risk of invasive multidrug-resistant infection

Published:2021-11 Issue: Volume: Page:
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Ghani Rohma,Mullish Benjamin H.,Davies Frances J.,Marchesi Julian R.

Funder

Imperial College Healthcare NHS Trust

Medical Research Council

NIHR Imperial Biomedical Research Centre

National Institute for Health Research

Imperial College London

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference47 articles.

1. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance;Magiorakos;Clin Microbiol Infect,2012

2. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation;Taur;Clin Infect Dis,2012

3. Effect of antimicrobial agents on the ecological balance of human microflora;Sullivan;Lancet Infect Dis,2001

4. Precision identification of diverse bloodstream pathogens in the gut microbiome;Tamburini;Nat Med,2018

5. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis;Righi;J Antimicrob Chemother,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection;Genome Medicine;2024-02-28

2. Long-term beneficial effect of faecal microbiota transplantation on colonisation of multidrug-resistant bacteria and resistome abundance in patients with recurrent Clostridioides difficile infection;2023-09-12

3. Faecal microbiota transplantation for first and second episodes of Clostridioides difficile infection;The Lancet Gastroenterology & Hepatology;2023-02

4. Gut colonisation with multidrug-resistant Klebsiella pneumoniae worsens Pseudomonas aeruginosa lung infection;Nature Communications;2023-01-05

5. The Concept of Intrauterine Programming and the Development of the Neonatal Microbiome in the Prevention of SARS-CoV-2 Infection;Nutrients;2022-04-20